covid
Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Craniopharyngioma: same dangers, different age…
Información de la revista
Vol. 54. Núm. 3.
Páginas 131-133 (marzo 2007)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 54. Núm. 3.
Páginas 131-133 (marzo 2007)
Editorial
Acceso a texto completo
Craniopharyngioma: same dangers, different age…
Visitas
3698
Joana Queirós, Ângela Magalhães, José Luis Medina
Autor para correspondencia
jlmedina@totel.pt

Correspondencia: Dr. J.L. Medina, Serviço de Endocrinología. Hospital de São João. Alameda Prof. Henãni Monteiro. 4200-319 Porto. Portugal.
Serviço de Endocrinologia. Faculdade de Medicina do Porto. Hospial de São João E.P.E. Porto. Portugal
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
REFERENCES
[1.]
C.K. Petito, U. DeGirolami, K.M. Earle.
Craniopharyngiomas. A clinical and pathological review.
Cancer, 37 (1976), pp. 1944-1952
[2.]
T.E. Adamson, O.D. Wiestler, P. Kleihues, M.G. Yasargil.
Correlation of clinical and pathological features in surgically treated craniopharyngiomas.
J Neurosurg, 3 (1990), pp. 12-17
[3.]
G.R. Bunin, T.S. Surawicz, P.A. Witman, S. Preston-Martin, F. Davis, J.M. Bruner.
The descriptive epidemiology of craniopharyngioma.
J Neurosurg, 89 (1998), pp. 547-551
[4.]
N. Karavitaki, C. Brufani, J.T. Warner, C.B.T. Adams, P. Richards, O. Ansorge, et al.
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
Clin Endocrinol (Oxf), 62 (2005), pp. 397-409
[5.]
F. Novegno, F. Di Rocco, C. Colosimo Jr, L. Lauriola, M. Caldarelli.
Ectopic recurrences of craniopharyngioma.
Childs Nerv Syst, 18 (2002), pp. 468-473
[6.]
CBTRUS. Primary brain tumors in the United States: statistical report 1998-2002. Central Brain Tumor Registry of the United States, 2005-2006.
[7.]
N. Karavitaki, S. Cudlip, C.B.T. Adams, J.A.H. Wass.
Craniopharyngiomas.
Endocr Rev, 27 (2006), pp. 371-397
[8.]
S. Meuric, R. Brauner, C. Trivin, J.C. Souberbielle, M. Zerah, C. Sainte-Rose.
Influence of tumor location on the presentation and evolution of craniopharyngiomas.
J Neurosurg, 103 (2005), pp. 421-426
[9.]
N.J. Ullrich, R.M. Scott, S.L. Pomeroy.
Craniopharyngioma therapy: long-term effects on hypothalamic function.
[10.]
R. Sorva, O. Heiskanen, J. Perheentupa.
Craniopharyngioma surgery in children: Endocrine and visual outcome.
Childs Nerv Syst, 4 (1988), pp. 97-99
[11.]
A.R. Lafferty, G.P. Chrousos.
Pituitary tumors in children and adolescents.
J Clin Endocrinol Metab, 84 (1999), pp. 4317-4323
[12.]
S.A. Spence, D.G. Taylor, S.R. Hirsch.
Depressive disorder due to craniopharyngioma.
J R Soc Med, 88 (1995), pp. 637
[13.]
B. Bülow, R. Attewell, L. Hagman, P. Malmstrom, C.H. Nordstrom, E.M. Erfurth.
Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.
J Clin Endocrinol Metab, 83 (1998), pp. 3897-3904
[14.]
A.M. Pereira, E.M. Schmid, P.J. Schutte, J.H. Voormolen, N.R. Biermasz, S.W. Van Thiel, et al.
High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
Clin Endocrinol, 62 (2005), pp. 197-204
[15.]
J.T. Hoff, R.H. Patterson.
Craniopharyngiomas in children and adults.
J Neurosurg, 36 (1972), pp. 299-302
[16.]
C.J. De Vile, D.B. Grant, B.E. Kendall, B.G.R. Neville, R. Stanhope, K.R. Watkins, et al.
Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted.
J Neurosurg, 85 (1996), pp. 73-81
[17.]
H.L. Weiner, J.H. Wisoff, M.E. Rosenberg, M.J. Kupersmith, H. Cohen, D. Zagzag, et al.
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Neurosurgery, 35 (1994), pp. 1001-1010
[18.]
C.A. Sklar.
Craniopharyngioma: endocrine sequelae of treatment.
Pediatr Neurosurg, 21 (1994), pp. 120-123
[19.]
M. Geffner, M. Lundberg, M. Koltowska-Haggstrom, A.B.S. Roger, J. Verhelst, E.M. Erfurth, et al.
Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
J Clin Endocrinol Metab, 89 (2004), pp. 5435-5440
[20.]
H. Muller, K. Bueb, U. Bartels, C.H. Roth, K. Harz, N. Graf, et al.
Obesity after childhood craniopharyngioma: German multicenter study on pre-operative risk factors and quality of life.
Klin Pediatr, 213 (2001), pp. 244-249
[21.]
S. Srinivasan, G.D. Ogle, S.P. Garnett, J.N. Briody, J.W. Lee, C.T. Cowell.
Features of the metabolic syndrome after childhood craniopharyngioma.
J Clin Endocrinol Metab, 89 (2004), pp. 81-86
[22.]
A.K. Maniatis, J.H. Simmons, P.S. Zeitler.
Hypothalamic obesity in a patient with craniopharyngioma dysregulation of neurohormonal control of energy balance.
Cur Opin Pediatr, 17 (2005), pp. 275-279
Copyright © 2007. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos